Details for New Drug Application (NDA): 071868
✉ Email this page to a colleague
The generic ingredient in CYTARABINE is cytarabine. There are fifteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the cytarabine profile page.
Summary for 071868
Tradename: | CYTARABINE |
Applicant: | Hospira |
Ingredient: | cytarabine |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 071868
Mechanism of Action | Nucleic Acid Synthesis Inhibitors |
Medical Subject Heading (MeSH) Categories for 071868
Suppliers and Packaging for NDA: 071868
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CYTARABINE | cytarabine | INJECTABLE;INJECTION | 071868 | ANDA | Hospira, Inc. | 61703-305 | 61703-305-38 | 5 VIAL, SINGLE-DOSE in 1 CARTON (61703-305-38) / 5 mL in 1 VIAL, SINGLE-DOSE (61703-305-58) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 20MG/ML | ||||
Approval Date: | Jun 4, 1990 | TE: | AP | RLD: | No |
Complete Access Available with Subscription